Genelex Corporation

Area of Science:

• Pharmacogenomics
• Clinical Pharmacology
• Health Informatics

Background:

• Adverse medication events are a significant healthcare burden.
• Personalized medication management and pharmacogenetic testing offer potential solutions.
• Current limitations include inadequate patient records and physician decision support for interpreting genetic data.

Purpose of the Study:

• To address the 'interpretation gap' in personalized pharmacology.
• To introduce GeneMedRx, an algorithm-driven software for gene-drug interaction analysis.
• To facilitate physician decision-making in optimizing medication regimens.

Main Methods:

• Development of GeneMedRx, a software utilizing algorithms for gene-drug correlation.
• Integration of patient genetic makeup with current medication data.
• Creation of portable personal health records.

Main Results:

• GeneMedRx effectively bridges the interpretation gap by correlating genetic profiles with drug data.
• The software aids physicians in optimizing medication regimens.
• Portable personal health records are generated for comprehensive medication management.

Conclusions:

• GeneMedRx provides a crucial tool for personalized medication management.
• The software supports physicians in leveraging pharmacogenetic information.
• Implementation of GeneMedRx can improve healthcare outcomes by reducing adverse drug events.